{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:08:49Z","timestamp":1790359729355,"version":"4.1.0"},"reference-count":331,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["J3545-B13"],"award-info":[{"award-number":["J3545-B13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00097","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T08:04:09Z","timestamp":1518422649000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":118,"title":["A New Classification System for IgG4 Autoantibodies"],"prefix":"10.3389","volume":"9","author":[{"given":"Inga","family":"Koneczny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients","volume":"84","author":"Keung","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/1756285611411503","article-title":"Response of patients with refractory myasthenia gravis to rituximab: a retrospective study","volume":"4","author":"Nowak","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00415-006-0442-2","article-title":"Rituximab in refractory MuSK antibody myasthenia gravis","volume":"254","author":"Thakre","year":"2007","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/mus.20479","article-title":"Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab","volume":"33","author":"Hain","year":"2006","journal-title":"Muscle Nerve"},{"key":"B13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1405.012","article-title":"Response to therapy in myasthenia gravis with anti-MuSK antibodies","volume":"1132","author":"Evoli","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J Autoimmun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis","volume":"244","author":"Mori","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"Morsch","year":"2012","journal-title":"Exp Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mus.20491","article-title":"Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis","volume":"33","author":"Farrugia","year":"2006","journal-title":"Muscle Nerve"},{"key":"B25","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jneuroim.2017.05.002","article-title":"Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies","volume":"309","author":"Mathey","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J Dermatol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1056\/NEJM198906013202206","article-title":"The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem)","volume":"320","author":"Rock","year":"1989","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMra061111","article-title":"Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome","volume":"355","author":"Stanley","year":"2006","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1067\/mjd.2003.7","article-title":"Desmoglein as a target in autoimmunity and infection","volume":"48","author":"Amagai","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1126\/science.1071559","article-title":"C-cadherin ectodomain structure and implications for cell adhesion mechanisms","volume":"296","author":"Boggon","year":"2002","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1073\/pnas.1606272113","article-title":"Structural basis of adhesive binding by desmocollins and desmogleins","volume":"113","author":"Harrison","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","article-title":"Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3","volume":"170","author":"Tsunoda","year":"2003","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1172\/JCI64413","article-title":"Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface","volume":"122","author":"Di Zenzo","year":"2012","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2133.2011.10463.x","article-title":"IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis","volume":"165","author":"Oktarina","year":"2011","journal-title":"Br J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/jid.2014.140","article-title":"Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies","volume":"134","author":"van der Wier","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1523-1747.1999.00463.x","article-title":"Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells","volume":"112","author":"Aoyama","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/jid.2010.389","article-title":"Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3","volume":"131","author":"Jennings","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e87809","DOI":"10.1371\/journal.pone.0087809","article-title":"Desmosome assembly and disassembly are membrane raft-dependent","volume":"9","author":"Stahley","year":"2014","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/jid.2008.339","article-title":"Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies","volume":"129","author":"Mao","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1074\/jbc.M512447200","article-title":"Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies","volume":"281","author":"Calkins","year":"2006","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e50696","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1172\/JCI44425","article-title":"Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity","volume":"120","author":"Yamagami","year":"2010","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/pde.12859","article-title":"Neonatal autoimmune blistering disease: a systematic review","volume":"33","author":"Zhao","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","volume":"5","author":"Cho","year":"2014","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1073\/pnas.1512561112","article-title":"High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome","volume":"112","author":"Casina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/trf.13583","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1111\/trf.13584","article-title":"ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro","volume":"56","author":"Ostertag","year":"2016","journal-title":"Transfusion"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/j.1538-7836.2009.03568.x","article-title":"IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura","volume":"7","author":"Ferrari","year":"2009","journal-title":"J Thromb Haemost"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e6547","DOI":"10.1097\/MD.0000000000006547","article-title":"Acquired idiopathic thrombotic thrombocytopenic purpura successfully treated with intravenous immunoglobulin and glucocorticoid: a case report","volume":"96","author":"Nakao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","article-title":"HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians","volume":"8","author":"Coppo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"B65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.humimm.2016.11.005","article-title":"The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura","volume":"78","author":"Sinkovits","year":"2017","journal-title":"Hum Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3324\/haematol.2013.094151","article-title":"Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura","volume":"99","author":"Ferrari","year":"2014","journal-title":"Haematologica"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1182\/blood-2010-04-280479","article-title":"Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)","volume":"116","author":"Feys","year":"2010","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1160\/TH04-05-0301","article-title":"The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura","volume":"93","author":"Luken","year":"2005","journal-title":"Thromb Haemost"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1182\/blood-2014-04-561142","article-title":"The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs","volume":"124","author":"Schaller","year":"2014","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"B74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1528-1167.2010.02756.x","article-title":"Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission","volume":"52","author":"Lalic","year":"2011","journal-title":"Epilepsia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamaneurol.2014.463","article-title":"Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy","volume":"71","author":"Irani","year":"2014","journal-title":"JAMA Neurol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5692\/clinicalneurol.cn-000964","article-title":"A case of anti-neurofascin 155 antibody-positive combined central and peripheral demyelination successfully treated with plasma exchange","volume":"57","author":"Shimizu","year":"2017","journal-title":"Rinsho Shinkeigaku"},{"key":"B83","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1212\/NXI.0000000000000127","article-title":"Caspr2 autoantibodies target multiple epitopes","volume":"2","author":"Olsen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflmm"},{"key":"B87","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fncel.2015.00265","article-title":"Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis","volume":"9","author":"Pinatel","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody-associated disease","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"Kortvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B90","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2015.03.005","article-title":"Clinical manifestations of patients with CASPR2 antibodies","volume":"281","author":"Sunwoo","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/mp.2016.165","article-title":"Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice","volume":"21","author":"Brimberg","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B95","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jns.2016.10.046","article-title":"Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report","volume":"372","author":"Sundal","year":"2017","journal-title":"J Neurol Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2013.01.040","article-title":"Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus","volume":"327","author":"Balint","year":"2013","journal-title":"J Neurol Sci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1172\/JCI72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s12026-016-8790-1","article-title":"IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study","volume":"64","author":"Yang","year":"2016","journal-title":"Immunol Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00467-009-1439-8","article-title":"IgG subclasses and complement pathway in segmental and global membranous nephropathy","volume":"25","author":"Segawa","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"B101","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2014050502","article-title":"Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy","volume":"26","author":"Fresquet","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1681\/ASN.2013121315","article-title":"Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy","volume":"26","author":"Kao","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ndt\/14.4.881","article-title":"Glomerular deposition of mannose-binding lectin in human glomerulonephritis","volume":"14","author":"Lhotta","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1681\/ASN.2012080771","article-title":"Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy","volume":"24","author":"Lv","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/eci.12545","article-title":"A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis","volume":"45","author":"Muller-Deile","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1681\/ASN.2017020178","article-title":"PLA2R and THSD7A: disparate paths to the same disease?","volume":"28","author":"Beck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fimmu.2016.00157","article-title":"Alternative pathway dysregulation and the conundrum of complement activation by IgG4 immune complexes in membranous nephropathy","volume":"7","author":"Borza","year":"2016","journal-title":"Front Immunol"},{"key":"B108","first-page":"62A","article-title":"Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway (abstract)","volume":"22","author":"Ma","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy","author":"Hayashi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1681\/ASN.2017010030","article-title":"A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"28","author":"Tomas","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1936372","DOI":"10.1155\/2017\/1936372","article-title":"Recent progress in deciphering the etiopathogenesis of primary membranous nephropathy","volume":"2017","author":"Kronbichler","year":"2017","journal-title":"Biomed Res Int"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0138841","DOI":"10.1371\/journal.pone.0138841","article-title":"Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy","volume":"10","author":"Iwakura","year":"2015","journal-title":"PLoS One"},{"key":"B115","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2169\/internalmedicine.55.6726","article-title":"Membranous nephropathy with an enhanced granular expression of thrombospondin type-1 domain-containing 7A in a pregnant woman","volume":"55","author":"Iwakura","year":"2016","journal-title":"Intern Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","article-title":"Circulating antibodies against thrombospondin type-I domain-containing 7A in chinese patients with idiopathic membranous nephropathy","volume":"12","author":"Wang","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.ajkd.2013.08.032","article-title":"Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease","volume":"63","author":"Ohlsson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.ki.5002525","article-title":"Antiglomerular basement membrane disease with normal renal function","volume":"72","author":"Cui","year":"2007","journal-title":"Kidney Int"},{"key":"B121","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.kint.2016.02.001","article-title":"The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis","volume":"89","author":"Nasr","year":"2016","journal-title":"Kidney Int"},{"key":"B122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2172-14-19","article-title":"The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease","volume":"14","author":"Qu","year":"2013","journal-title":"BMC Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.kint.2016.01.018","article-title":"Glomerular disease with idiopathic linear immunoglobulin deposition: a rose by any other name would be atypical","volume":"89","author":"Rosales","year":"2016","journal-title":"Kidney Int"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","article-title":"DPPX antibody-associated encephalitis: main syndrome and antibody effects","volume":"88","author":"Hara","year":"2017","journal-title":"Neurology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1212\/NXI.0000000000000361","article-title":"Anti-DPPX encephalitis: prominent nystagmus reflected by extraocular muscle FDG-PET avidity","volume":"4","author":"Doherty","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B127","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","article-title":"Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons","volume":"85","author":"Piepgras","year":"2015","journal-title":"Neurology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat","year":"2013","journal-title":"Ann Neurol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"B130","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B132","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.09.012","article-title":"Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy","volume":"300","author":"Haitao","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1212\/NXI.0000000000000383","article-title":"IgLON5 disease responsive to immunotherapy","volume":"4","author":"Bonello","year":"2017","journal-title":"Neurolo Neuroimmunol Neuroinflamm"},{"key":"B134","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(15)60445-7","article-title":"IgLON5 autoimmunity and abnormal behaviours during sleep","volume":"385","author":"Hogl","year":"2015","journal-title":"Lancet"},{"key":"B136","first-page":"1","article-title":"IgG subclasses. A historical perspective","volume":"23","author":"Schur","year":"1988","journal-title":"Monogr Allergy"},{"key":"B137","first-page":"100","article-title":"Serum IgG subclasses in normal adults","volume":"19","author":"French","year":"1986","journal-title":"Monogr Allergy"},{"key":"B138","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0022-1759(84)90376-4","article-title":"Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies","volume":"74","author":"Aucouturier","year":"1984","journal-title":"J Immunol Methods"},{"key":"B139","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/294088a0","article-title":"Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae","volume":"294","author":"Briles","year":"1981","journal-title":"Nature"},{"key":"B140","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0161-5890(80)90139-X","article-title":"Isotypes of mouse IgG \u2013 I. Evidence for \u2019non-complement-fixing\u2019 IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement","volume":"17","author":"Ey","year":"1980","journal-title":"Mol Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"Germann","year":"1995","journal-title":"Eur J Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"B143","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/216941a0","article-title":"Disulphide bridges of a human immunoglobulin G protein","volume":"216","author":"Pinck","year":"1967","journal-title":"Nature"},{"key":"B144","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/216939b0","article-title":"Disulphide bridges of immunoglobulin G-1 heavy chains","volume":"216","author":"Frangione","year":"1967","journal-title":"Nature"},{"key":"B145","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/221145a0","article-title":"Structural studies of immunoglobulin G","volume":"221","author":"Frangione","year":"1969","journal-title":"Nature"},{"key":"B146","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-0036-1584322","article-title":"The immunobiology of immunoglobulin G4","volume":"36","author":"Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1529\/biophysj.107.108993","article-title":"Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation","volume":"93","author":"Lu","year":"2007","journal-title":"Biophys J"},{"key":"B149","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/BJ20100641","article-title":"Masking of the Fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy","volume":"432","author":"Abe","year":"2010","journal-title":"Biochem J"},{"key":"B150","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.178.2.661","article-title":"Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation","volume":"178","author":"Tao","year":"1993","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/eji.1830241042","article-title":"Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis","volume":"24","author":"Brekke","year":"1994","journal-title":"Eur J Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1084\/jem.173.6.1483","article-title":"The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region","volume":"173","author":"Canfield","year":"1991","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"16469","DOI":"10.1074\/jbc.M100350200","article-title":"The structure of a human type III Fcgamma receptor in complex with Fc","volume":"276","author":"Radaev","year":"2001","journal-title":"J Biol Chem"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0161-5890(01)00050-5","article-title":"The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds","volume":"38","author":"Schuurman","year":"2001","journal-title":"Mol Immunol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/pro.5560060217","article-title":"Intrachain disulfide bond in the core hinge region of human IgG4","volume":"6","author":"Bloom","year":"1997","journal-title":"Protein Sci"},{"key":"B158","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0161-5890(93)90432-B","article-title":"A single amino acid substitution abolishes the heterogeneity of chimeric mouse\/human (IgG4) antibody","volume":"30","author":"Angal","year":"1993","journal-title":"Mol Immunol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2012.10.029","article-title":"Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of Fab-arm exchange","volume":"54","author":"Davies","year":"2013","journal-title":"Mol Immunol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.4049\/jimmunol.1003336","article-title":"Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength","volume":"187","author":"Labrijn","year":"2011","journal-title":"J Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/bj2810317","article-title":"Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab\u2019 fragment","volume":"281","author":"King","year":"1992","journal-title":"Biochem J"},{"key":"B162","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.iy.06.040188.002535","article-title":"Nonprecipitating asymmetric antibodies","volume":"6","author":"Margni","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"B163","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.4049\/jimmunol.137.11.3566","article-title":"Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency","volume":"137","author":"van der Zee","year":"1986","journal-title":"J Immunol"},{"key":"B164","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1016\/S0021-9258(20)79774-7","article-title":"An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G","volume":"249","author":"Petersen","year":"1974","journal-title":"J Biol Chem"},{"key":"B165","first-page":"1738","article-title":"Characterization and biodistribution of recombinant and recombinant\/chimeric constructs of monoclonal antibody B72.3","volume":"49","author":"Colcher","year":"1989","journal-title":"Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"key":"B167","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1074\/jbc.M113.541813","article-title":"Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange","volume":"289","author":"Rispens","year":"2014","journal-title":"J Biol Chem"},{"key":"B168","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B171","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1016\/j.molimm.2009.07.031","article-title":"The in vitro biological activity of the HLA-DR-binding clinical IgG4 antibody 1D09C3 is a consequence of the disruption of cell aggregates and can be abrogated by Fab arm exchange","volume":"46","author":"Hansen","year":"2009","journal-title":"Mol Immunol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nbt.1553","article-title":"Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo","volume":"27","author":"Labrijn","year":"2009","journal-title":"Nat Biotechnol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/imm.12265","article-title":"Estimation of polyclonal IgG4 hybrids in normal human serum","volume":"142","author":"Young","year":"2014","journal-title":"Immunology"},{"key":"B174","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1021\/ja203638y","article-title":"Mechanism of immunoglobulin G4 Fab-arm exchange","volume":"133","author":"Rispens","year":"2011","journal-title":"J Am Chem Soc"},{"key":"B175","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1124\/dmd.109.029751","article-title":"Impact of molecular processing in the hinge region of therapeutic IgG4 antibodies on disposition profiles in cynomolgus monkeys","volume":"38","author":"Stubenrauch","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/j.molimm.2010.02.021","article-title":"Hybrid IgG4\/IgG4 Fc antibodies form upon \u2019Fab-arm\u2019 exchange as demonstrated by SDS-PAGE or size-exclusion chromatography","volume":"47","author":"Rispens","year":"2010","journal-title":"Mol Immunol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.freeradbiomed.2009.08.021","article-title":"Measuring the poise of thiol\/disulfide couples in vivo","volume":"47","author":"Jones","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"B178","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jpba.2011.01.006","article-title":"Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri(R)) with endogenous IgG4","volume":"55","author":"Shapiro","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"B179","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.iac.2008.06.006","article-title":"Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes","volume":"28","author":"Bonilla","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"B180","unstructured":"KonecznyI OxfordOxford UniversityPotential Mechanisms in MuSK Myasthenia Gravis2014"},{"key":"B181","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.4049\/jimmunol.0804338","article-title":"Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions","volume":"182","author":"Rispens","year":"2009","journal-title":"J Immunol"},{"key":"B182","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.155.10.5057","article-title":"Localization of an Fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis","volume":"155","author":"Zack","year":"1995","journal-title":"J Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"e1637","DOI":"10.1371\/journal.pone.0001637","article-title":"A novel immunoglobulin-immunoglobulin interaction in autoimmunity","volume":"3","author":"Kawa","year":"2008","journal-title":"PLoS One"},{"key":"B184","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4049\/jimmunol.139.5.1466","article-title":"The subclass distribution of human IgG rheumatoid factor","volume":"139","author":"Cohen","year":"1987","journal-title":"J Immunol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2559.2010.03717.x","article-title":"Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis","volume":"57","author":"Detlefsen","year":"2010","journal-title":"Histopathology"},{"key":"B186","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"key":"B188","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4049\/jimmunol.101.2.317","article-title":"A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody","volume":"101","author":"Lichtenstein","year":"1968","journal-title":"J Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1084\/jem.20080193","article-title":"In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure","volume":"205","author":"Meiler","year":"2008","journal-title":"J Exp Med"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors","volume":"63","author":"Meiler","year":"2008","journal-title":"Allergy"},{"key":"B192","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","article-title":"T regulatory-1 cells induce IgG4 production by B cells: role of IL-10","volume":"174","author":"Satoguina","year":"2005","journal-title":"J Immunol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000233787","article-title":"The role of IgG4 as blocking antibodies in asthmatics and in bee keepers","volume":"77","author":"Nakagawa","year":"1985","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(00)04168-4","article-title":"Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study","volume":"357","author":"Platts-Mills","year":"2001","journal-title":"Lancet"},{"key":"B198","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaci.2012.04.006","article-title":"Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy","volume":"130","author":"James","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2500\/108854187778999667","article-title":"IgG4 and hyposensitization","volume":"8","author":"Van der Zee","year":"1987","journal-title":"N Engl Reg Allergy Proc"},{"key":"B200","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"B201","first-page":"681","article-title":"Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies","volume":"41","author":"Margni","year":"1980","journal-title":"Immunology"},{"key":"B202","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000233000","article-title":"IgG4 and release of histamine from human peripheral blood leukocytes","volume":"67","author":"van Toorenenbergen","year":"1982","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"B203","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02991163","article-title":"IgG4 as a blocking antibody","volume":"1","author":"Aalberse","year":"1983","journal-title":"Clin Rev Allergy"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jaci.2015.01.012","article-title":"IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens","volume":"135","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0091-6749(83)90503-1","article-title":"Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens","volume":"72","author":"Kemeny","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"B206","first-page":"150","article-title":"Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy","volume":"18","author":"Kemeny","year":"1983","journal-title":"Monogr Allergy"},{"key":"B207","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4269\/ajtmh.1996.55.197","article-title":"Neutralization of bee venom lethality by immune serum antibodies","volume":"55","author":"Schumacher","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJM197805182982004","article-title":"Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation","volume":"298","author":"Drachman","year":"1978","journal-title":"N Engl J Med"},{"key":"B209","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1073\/pnas.74.7.3090","article-title":"Modulation of acetylcholine receptor by antibody against the receptor","volume":"74","author":"Heinemann","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B210","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"B211","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann Neurol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","article-title":"Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies","volume":"77","author":"Peng","year":"2015","journal-title":"Ann Neurol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/icb.2013.5","article-title":"Enhanced cell-binding by allergen multimers: how complex is it?","volume":"91","author":"Collins","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.iy.11.040193.000455","article-title":"The role of autoantibodies in autoimmune disease","volume":"11","author":"Naparstek","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis","volume":"183","author":"Skeie","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","article-title":"Chronic thyroiditis and autoimmunization","volume":"164","author":"Witebsky","year":"1957","journal-title":"J Am Med Assoc"},{"key":"B218","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"B219","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.0022-202X.2005.23714.x","article-title":"In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris","volume":"124","author":"Ishii","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"e0156800","DOI":"10.1371\/journal.pone.0156800","article-title":"Pathogenicity and epitope characteristics do not differ in IgG subclass-switched anti-desmoglein 3 IgG1 and IgG4 autoantibodies in pemphigus vulgaris","volume":"11","author":"Lo","year":"2016","journal-title":"PLoS One"},{"key":"B222","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1083\/jcb.200605125","article-title":"Inhibition of Rho A activity causes pemphigus skin blistering","volume":"175","author":"Waschke","year":"2006","journal-title":"J Cell Biol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4049\/jimmunol.182.1.711","article-title":"Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fimmu.2017.01022","article-title":"Crosstalk between signaling pathways in pemphigus: a role for endoplasmic reticulum stress in p38 mitogen-activated protein kinase activation?","volume":"8","author":"Cipolla","year":"2017","journal-title":"Front Immunol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1111\/bjd.15721","article-title":"Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis","volume":"177","author":"Egu","year":"2017","journal-title":"Br J Dermatol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"728529","DOI":"10.1155\/2013\/728529","article-title":"p38 MAPK signaling in pemphigus: implications for skin autoimmunity","volume":"2013","author":"Mavropoulos","year":"2013","journal-title":"Autoimmune Dis"},{"key":"B227","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.4049\/jimmunol.1002675","article-title":"Protective endogenous cyclic adenosine 5\u2019-monophosphate signaling triggered by pemphigus autoantibodies","volume":"185","author":"Spindler","year":"2010","journal-title":"J Immunol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1038\/s41598-017-03697-7","article-title":"Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus","volume":"7","author":"Walter","year":"2017","journal-title":"Sci Rep"},{"key":"B229","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms causing loss of keratinocyte cohesion in pemphigus","volume":"138","author":"Spindler","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0960-8966(17)30325-5","article-title":"Inhibition of the tyrosine phosphatase Shp2 alleviates the pathogenic effects of MuSK antibodies in vitro","volume":"27","author":"Huda","year":"2007","journal-title":"Neuromuscul Dis"},{"key":"B231","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"B232","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"key":"B233","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"key":"B234","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ebiom.2015.06.007","article-title":"Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura","volume":"2","author":"Thomas","year":"2015","journal-title":"EBioMedicine"},{"key":"B235","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B236","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fncel.2013.00196","article-title":"Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases","volume":"7","author":"Faivre-Sarrailh","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"B237","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/emboj\/16.5.978","article-title":"Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions","volume":"16","author":"Peles","year":"1997","journal-title":"EMBO J"},{"key":"B238","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.20-22-08354.2000","article-title":"Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination","volume":"20","author":"Rios","year":"2000","journal-title":"J Neurosci"},{"key":"B239","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0960-9822(01)00680-7","article-title":"Neurofascin is a glial receptor for the paranodin\/Caspr-contactin axonal complex at the axoglial junction","volume":"12","author":"Charles","year":"2002","journal-title":"Curr Biol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"key":"B241","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","article-title":"Human IgA activates the complement system via the mannan-binding lectin pathway","volume":"167","author":"Roos","year":"2001","journal-title":"J Immunol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1681\/ASN.2015101155","article-title":"Phospholipase A2 receptor-related membranous nephropathy and mannan-binding lectin deficiency","volume":"27","author":"Bally","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/eci.12292","article-title":"Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen","volume":"44","author":"Skoberne","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"B246","doi-asserted-by":"publisher","first-page":"7935","DOI":"10.1074\/jbc.M113.512780","article-title":"Complex determinants in specific members of the mannose receptor family govern collagen endocytosis","volume":"289","author":"Jurgensen","year":"2014","journal-title":"J Biol Chem"},{"key":"B247","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00275.2016","article-title":"Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes","volume":"311","author":"Foster","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"B249","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"S277","DOI":"10.1097\/JTO.0b013e3181f23f04","article-title":"Caspr2 antibodies in patients with thymomas","volume":"5","author":"Vincent","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B252","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(16)31459-3","article-title":"Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies","volume":"389","author":"Vale","year":"2017","journal-title":"Lancet"},{"key":"B253","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","article-title":"Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes","volume":"137","author":"Carvajal-Gonzalez","year":"2014","journal-title":"Brain"},{"key":"B254","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3899\/jrheum.131017","article-title":"Individuals with IgG4-related disease do not have an increased frequency of the K409 variant of IgG4 that compromises Fab-arm exchange","volume":"41","author":"Ahmad","year":"2014","journal-title":"J Rheumatol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"27415","DOI":"10.1038\/srep27415","article-title":"Hybrid kappa\\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer","volume":"6","author":"Hao","year":"2016","journal-title":"Sci Rep"},{"key":"B256","doi-asserted-by":"publisher","first-page":"2953072","DOI":"10.1155\/2016\/2953072","article-title":"Increased kappa\/lambda hybrid antibody in serum is a novel biomarker related to disease activity and inflammation in rheumatoid arthritis","volume":"2016","author":"Yi","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B257","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"B258","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1212\/WNL.28.8.804","article-title":"Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes","volume":"28","author":"Shibuya","year":"1978","journal-title":"Neurology"},{"key":"B259","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1749-6632.1993.tb22936.x","article-title":"Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function","volume":"681","author":"Vincent","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"B260","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1210\/edrv.19.6.0352","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"B261","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/289594a0","article-title":"Thyroid growth-blocking antibodies in primary myxoedema","volume":"289","author":"Drexhage","year":"1981","journal-title":"Nature"},{"key":"B262","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"B263","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00005072-198003000-00005","article-title":"Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis","volume":"39","author":"Sahashi","year":"1980","journal-title":"J Neuropathol Exp Neurol"},{"key":"B264","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.1981.tb33725.x","article-title":"Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity","volume":"377","author":"Lennon","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"B265","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-013-1116-7","article-title":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica","volume":"125","author":"Misu","year":"2013","journal-title":"Acta Neuropathol"},{"key":"B266","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","author":"Binks","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B268","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Res"},{"key":"B269","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"B270","first-page":"1","article-title":"Cellular and molecular aspects of Goodpasture syndrome","volume":"6","author":"Alenzi","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"B271","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/1346-8138.12675","article-title":"Update on fogo selvagem, an endemic form of pemphigus foliaceus","volume":"42","author":"Aoki","year":"2015","journal-title":"J Dermatol"},{"key":"B272","doi-asserted-by":"publisher","first-page":"WC01","DOI":"10.7860\/JCDR\/2017\/21868.9717","article-title":"Rituximab: a magic bullet for pemphigus","volume":"11","author":"Anandan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/S0140-6736(17)30787-0","article-title":"Rituximab as first-line treatment of pemphigus","volume":"389","author":"Schmidt","year":"2017","journal-title":"Lancet"},{"key":"B274","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/bjd.12972","article-title":"Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study","volume":"170","author":"Kanwar","year":"2014","journal-title":"Br J Dermatol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.expneurol.2016.10.006","article-title":"Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins","volume":"287","author":"Appeltshauser","year":"2017","journal-title":"Exp Neurol"},{"key":"B276","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-170189","article-title":"Microglial and neuronal TDP-43 pathology in anti-IgLON5-related tauopathy","volume":"59","author":"Cagnin","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B278","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Exp Neurol"},{"key":"B279","doi-asserted-by":"publisher","first-page":"16556","DOI":"10.1073\/pnas.1408409111","article-title":"The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses","volume":"111","author":"Tezuka","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B280","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction","volume":"19","author":"Maselli","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1523\/JNEUROSCI.4130-07.2008","article-title":"Muscle-specific receptor tyrosine kinase endocytosis in acetylcholine receptor clustering in response to agrin","volume":"28","author":"Zhu","year":"2008","journal-title":"J Neurosci"},{"key":"B282","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1111\/febs.12309","article-title":"Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin","volume":"280","author":"Luiskandl","year":"2013","journal-title":"FEBS J"},{"key":"B283","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.bbamcr.2011.03.005","article-title":"Rin-like, a novel regulator of endocytosis, acts as guanine nucleotide exchange factor for Rab5a and Rab22","volume":"1813","author":"Woller","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B284","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1182\/blood-2003-05-1616","article-title":"Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura","volume":"102","author":"Scheiflinger","year":"2003","journal-title":"Blood"},{"key":"B285","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"Huang","year":"2013","journal-title":"Mod Pathol"},{"key":"B286","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jneuroim.2017.02.004","article-title":"Is MuSK myasthenia gravis linked to IgG4-related disease?","volume":"305","author":"Raibagkar","year":"2017","journal-title":"J Neuroimmunol"},{"key":"B287","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/acr.20484","article-title":"Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13","volume":"63","author":"Saeki","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B288","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","article-title":"Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations","volume":"64","author":"Stone","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B289","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/BOR.0000000000000383","article-title":"IgG4-related disease","volume":"29","author":"Bozzalla Cassione","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"B290","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.07.038","article-title":"On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease","author":"Trampert","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"B291","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1136\/annrheumdis-2017-211330","article-title":"How to diagnose IgG4-related disease","volume":"76","author":"Umehara","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B292","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment \u2013 guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B293","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B294","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7326\/0003-4819-156-5-201203060-00025","article-title":"IgG4-related pachymeningitis: evidence of intrathecal IgG4 on cerebrospinal fluid analysis","volume":"156","author":"Della Torre","year":"2012","journal-title":"Ann Intern Med"},{"key":"B295","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"key":"B296","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28568","article-title":"Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies","volume":"64","author":"Doorenspleet","year":"2016","journal-title":"Hepatology"},{"key":"B297","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/ajg.2010.141","article-title":"Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process","volume":"105","author":"Lohr","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"B298","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.mpa.0000226881.48204.fd","article-title":"Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis","volume":"33","author":"Asada","year":"2006","journal-title":"Pancreas"},{"key":"B299","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","article-title":"Pathogenicity of IgG in patients with IgG4-related disease","volume":"65","author":"Shiokawa","year":"2016","journal-title":"Gut"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314548","article-title":"Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease","author":"Hubers","year":"2017","journal-title":"Gut"},{"key":"B301","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"B302","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jaut.2005.03.006","article-title":"Genetic factors in pemphigus","volume":"24","author":"Tron","year":"2005","journal-title":"J Autoimmun"},{"key":"B303","doi-asserted-by":"publisher","first-page":"A379","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B304","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM200007063430104","article-title":"The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research","volume":"343","author":"Warren","year":"2000","journal-title":"N Engl J Med"},{"key":"B305","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1038\/jid.2012.205","article-title":"Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection","volume":"132","author":"Gomes","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B306","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J Immunol"},{"key":"B307","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.4049\/jimmunol.1502233","article-title":"Overlapping IgG4 responses to self- and environmental antigens in endemic pemphigus foliaceus","volume":"196","author":"Qian","year":"2016","journal-title":"J Immunol"},{"key":"B308","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.jid.5701121","article-title":"The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus","volume":"128","author":"Diaz","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B309","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/jid.2014.430","article-title":"IgE anti-LJM11 sand fly salivary antigen may herald the onset of fogo selvagem in endemic Brazilian regions","volume":"135","author":"Qian","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B310","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jid.2010.403","article-title":"IgE, IgM, and IgG4 anti-desmoglein 1 autoantibody profile in endemic pemphigus foliaceus (fogo selvagem)","volume":"131","author":"Qian","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1084\/jem.20022031","article-title":"The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem)","volume":"197","author":"Li","year":"2003","journal-title":"J Exp Med"},{"key":"B312","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2008.189","article-title":"Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem)","volume":"129","author":"Qaqish","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B313","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1523-1747.2003.12017.x","article-title":"The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus","volume":"120","author":"Warren","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B314","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/MEG.0b013e3283297417","article-title":"Allergic manifestations in autoimmune pancreatitis","volume":"21","author":"Kamisawa","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B315","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2014-206405","article-title":"Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease","volume":"74","author":"Culver","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B316","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","article-title":"Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease","volume":"15","author":"Culver","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B317","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.4049\/jimmunol.180.5.3279","article-title":"Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones","volume":"180","author":"Tian","year":"2008","journal-title":"J Immunol"},{"key":"B318","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4049\/jimmunol.1600567","article-title":"Determinants of VH1-46 cross-reactivity to pemphigus vulgaris autoantigen desmoglein 3 and rotavirus antigen VP6","volume":"197","author":"Cho","year":"2016","journal-title":"J Immunol"},{"key":"B319","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.imbio.2015.12.005","article-title":"The immunobiology of Campylobacter jejuni: innate immunity and autoimmune diseases","volume":"221","author":"Phongsisay","year":"2016","journal-title":"Immunobiology"},{"key":"B320","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1681\/ASN.2014090877","article-title":"The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of pi","volume":"26","author":"Beck","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B321","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"key":"B322","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2215\/CJN.09930911","article-title":"Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury","volume":"7","author":"Jia","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B323","doi-asserted-by":"publisher","first-page":"e0174553","DOI":"10.1371\/journal.pone.0174553","article-title":"Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"key":"B324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lrr.2017.06.001","article-title":"EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult","volume":"8","author":"Oka","year":"2017","journal-title":"Leuk Res Rep"},{"key":"B325","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2169\/internalmedicine.49.2957","article-title":"Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor","volume":"49","author":"Kosugi","year":"2010","journal-title":"Intern Med"},{"key":"B326","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1537-2995.2009.02391.x","article-title":"A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection","volume":"50","author":"Rossi","year":"2010","journal-title":"Transfusion"},{"key":"B327","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MBC.0000000000000058","article-title":"Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination","volume":"25","author":"Kojima","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B328","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00063-010-1107-6","article-title":"[Very severe thrombotic thrombocytopenic purpura (TTP) after H1N1 vaccination]","volume":"105","author":"Hermann","year":"2010","journal-title":"Med Klin"},{"key":"B329","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1053\/j.ajkd.2006.04.090","article-title":"Recurrent idiopathic thrombotic thrombocytopenic purpura: a role for vaccination in disease relapse?","volume":"48","author":"Brodin-Sartorius","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"B330","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res"},{"key":"B331","doi-asserted-by":"publisher","first-page":"60539","DOI":"10.18632\/oncotarget.16966","article-title":"Expression, prognosis and functional role of Thsd7a in esophageal squamous cell carcinoma of Kazakh patients, Xinjiang","volume":"8","author":"Hou","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T19:15:41Z","timestamp":1693509341000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":331,"alternative-id":["10.3389\/fimmu.2018.00097"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00097","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"article-number":"97"}}